Table: Sinphar Pharmaceutical May Rev NT$300.8M Vs NT$272.6M

Sinphar Pharmaceutical Co. Ltd. - Taiwan Figures in New Taiwan dollars. 2026 2025 Revenue NT$300,796,000 NT$272,611,000 Jan-May Revenue NT$1,418,493,000 NT$1,349,318,000 Source: Taiwan Stock Exchange This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.